Insider filing · TVTX
William E. Rote
SENIOR VICE PRESIDENT, R&D
profile →
Travere Therapeutics, Inc.
TVTX · Healthcare · 74 filings in 24 months
ticker →
William E. Rote sold $409K of Travere Therapeutics (TVTX)
Executed Feb 3, disclosed Feb 3, the same day.
Value, as filed
$409K
12,446 sh × $32.87
Executed
Feb 3
the trade date, as filed
Disclosed
Feb 3
0 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
WRWilliam E. Rote (SENIOR VICE PRESIDENT, R&D) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Travere Therapeutics, Inc. (TVTX). The largest single filing was $13.1M of TVTX (208,778 sh across 5 lots, as filed), executed Sep 15.
The name
TVTXHealthcare · Travere Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by William E. Rote in TVTX
TVTXSALE
Travere Therapeutics, Inc.
$13.1M208,778 sh across 5 lots
Exec Sep 15
Filed Sep 17 · 9:35 PM ET TVTXSALE Travere Therapeutics, Inc. $121K
2,763 sh × $43.95
Exec May 6
Filed May 6 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. $356K
9,100 sh × $39.09
Exec Apr 22
Filed Apr 23 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. $2.4M
60,000 sh × $40.10
Exec Dec 24 2025
Filed Dec 29 2025 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. $122K
5,200 sh × $23.53
Exec Feb 12 2025
Filed Feb 12 2025 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. $177K
8,951 sh × $19.78
Exec Feb 3 2025
Filed Feb 4 2025 · 5:30 PM ET